Home » Topics » BioWorld Science

BioWorld Science
RSS

Amgen initiates phase I trials with KGF

April 26, 1996

Byk Gulden claims agents for H. pylori control

April 26, 1996

Enadoline claimed for treatment of BPH

April 26, 1996

5alpha-Reductase inhibitors for BPH disclosed by Lilly

April 26, 1996

SR-48692 claimed for use as diuretic

April 26, 1996

Terumo presents two new fibrinogen receptor antagonists

April 26, 1996

Genelabs develops two oral antithrombotics

April 26, 1996

NOS inhibitors claimed by Ono

April 26, 1996

Japanese investigators reveal new agent for heart failure

April 26, 1996

BMS-193884 in development for heart failure

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...